Rute Lopes

Rute Lopes

Auto-generated profile, based on publicly available information

Rute Lopes

Universidade Estadual Paulista

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
JCJuliana Cecchetto
Juliana Cecchetto
FFFlávio C.B. Fernandes
Flávio C.B. Fernandes
RLRute Lopes
Rute Lopes
PBPaulo Roberto Bueno
Paulo Roberto Bueno

22 December 2014 in International Journal of Biomaterials
Verified
Journal Article
Open access
PDF file
HMHeitor Dias Murbach
Heitor Dias Murbach
GOGuilherme Jaques Ogawa
Guilherme Jaques Ogawa
FBFelipe Azevedo Borges
Felipe Azevedo Borges
MMMatheus Carlos Romeiro Miranda
Matheus Carlos Romeiro Miranda
RLRute Lopes
Rute Lopes
RHRondinelli Donizetti Herculano
Rondinelli Donizetti Herculano
Natural rubber latex (NRL) fromHevea brasiliensisis easily manipulated, low cost, is of can stimulate natural angiogenesis and cellular adhesion, is a biocompatible, material and presents high mechanical resistance. Ciprofloxacin (CIP) is a synthetic antibiotic (fluoroquinolone) used in the treatment of infection at external fixation screws sites and remote infections, and this use is increasingly frequent in medical practice. The aim of this study was to develop a novel sustained delivery system for CIP based on NRL membranes and to study its delivery system behavior. CIP was found to be adsorbed on the NRL membrane, according to results of energy dispersive X-ray spectroscopy. Results show that the membrane can release CIP for up to 59.08% in 312 hours and the mechanism is due to super case II (non-Fickian). The kinetics of the drug release could be fitted with double exponential function X-ray diffraction and Fourier transform infrared (FTIR) spectroscopy shows some interaction by hydrogen bound, which influences its mechanical behavior.

3 July 2020 in Acta Scientiarum. Biological Sciences
Verified
Journal Article
Open access
PDF file
RLRute Lopes
Rute Lopes
MSMoema Souza Santana
Moema Souza Santana
CCCarla Rios da Cruz
Carla Rios da Cruz
RFRafael Bianchini Fulindi
Rafael Bianchini Fulindi
AGAna Maria Minarelli Gaspar
Ana Maria Minarelli Gaspar
PCPaulo Inacio Da Costa
Paulo Inacio Da Costa
The liver is primarily responsible for energy homeostasis and the regulation of lipid, carbohydrate and protein metabolism. Lipid metabolism consists of distributing lipids to peripheral tissues or ensuring their return to the liver to be reprocessed. Additionally, cellular metabolism is regulated by several molecules in different signaling pathways. Lipid homeostasis in the liver is mainly regulated by AKT, AMPK, SREBP, PPAR, and JNK. The PI3K/AKT/mTOR signaling pathway results in the biosynthesis of macromolecules and regulates lipogenesis and the expression of lipogenic genes. AMPK is an energy sensor that regulates metabolism and is activated when stored ATP is depleted, and it is responsible for the suppression of several key lipogenic factors in the liver related to cholesterol and fatty acid synthesis. SREBPs control lipogenic gene expression and cholesterol metabolism and act in the nutritional regulation of fatty acids and triglycerides. The continued activation of SREBPs is associated with cellular stress, inflammation and ultimately steatosis. PPARs are intrinsically important regulators of lipid metabolism. These genes are essential to various metabolic processes, especially lipid and glucose homeostasis, and can play a role in cell differentiation. JNK signaling is related to insulin resistance and its activation results in decreased mitochondrial activity and fat accumulation. Therefore, the study of cell signaling pathways related to lipid metabolism and liver function may help to identify abnormalities and develop strategies to manage and regulate metabolic disorders and resulting complications.

17 May 2021 in Current Nutrition & Food Science
Verified
Journal Article
Closed access
PDF file
MSMoema S. Santana
Moema S. Santana
RLRute Lopes
Rute Lopes
IPIsabela H. Peron
Isabela H. Peron
CCCarla R. Cruz
Carla R. Cruz
AGAna M. M. Gaspar
Ana M. M. Gaspar
PCPaulo Inacio Da Costa
Paulo Inacio Da Costa
Background: Hepatitis C virus infection is a significant global health burden, which causes acute or chronic hepatitis. Acute hepatitis C is generally asymptomatic and progresses to cure, while persistent infection can progress to chronic liver disease and extrahepatic manifestations. Standard treatment is expensive, poorly tolerated, and has variable sustained virologic responses amongst the different viral genotypes. New therapies involve direct acting antivirals; however, it is also very expensive and may not be accessible for all patients worldwide. In order to provide a complementary approach to the already existing therapies, natural bioactive compounds are investigated as to their several biologic activities, such as direct antiviral properties against hepatitis C, and effects on mitigating chronic progression of the disease, which include hepatoprotective, antioxidant, anticarcinogenic and anti-inflammatory activities; additionally, these compounds present advantages, as chemical diversity, low cost of production and milder or inexistent side effects. Objective: To present a broad perspective on hepatitis C infection, the chronic disease, and natural compounds with promising anti-HCV activity. Methods: This review consists of a systematic review study about the natural bioactive compounds as a potential therapy for hepatitis C infection. Results: The quest for natural products has yielded compounds with biologic activity, including viral replication inhibition in vitro, demonstrating antiviral activity against hepatitis C. Conclusion: One of the greatest advantages of using natural molecules from plant extracts is the low cost of production, not requiring chemical synthesis, which can lead to less expensive therapies available to low and middle-income countries.

14 October 2021 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
RLR. Lopes
R. Lopes
ISI. Saavedra‐Rocha
I. Saavedra‐Rocha
MMaria Jose Alves
Maria Jose Alves
MBMerce Bernardo
Merce Bernardo
DDDusan Djokovic
Dusan Djokovic
Click on the article title to read more.

25 March 2025 in Revista Fitos
Verified
Journal Article
Open access
RLRute Lopes
Rute Lopes
LTLorrane Davi Brito de Toledo
Lorrane Davi Brito de Toledo
ERElisandra Márcia Rodrigues
Elisandra Márcia Rodrigues
AGAna Maria Minarelli Gaspar
Ana Maria Minarelli Gaspar
PCPaulo Inacio Da Costa
Paulo Inacio Da Costa
Natural bioactive compounds (NBCs) has been reported to possess antiviral and hepatoprotective effects, like curcumin (CL) and piperine (PP). Herein, we report a study of hepatitis C virus biosynthesis and its molecular mechanisms in human hepatocarcinoma cells, expressing or not the HCV (SGR-JFH1) when exposed to CL, PP and its association (CL/PP). Inhibiting concentration (IC50) to CL were 30,95 ± 1,05 µM for Huh-7.5 and 41,96 ± 1,02 µM for SGR-JFH1 cells. For PP, the IC50 were 165,4 ± 1,15 and 200,3 ± 1,05 µM for Huh-7.5 and SGR-JFH1, respectively. An decrease in Cl/PP IC50 were observed with 26,02 ± 1,05 µM for Huh-7.5 and 19,74 ± 1,02 µM for SGR-JFH1. CL and PP induced inhibition of apoptosis. CL treatment at IC20 caused a slight increase of AMPK-α phosphorylation pathway in SGR-JFH1. Caspase-3 was expressed in IC10, and the other pathways were inhibited. HCV cells exposed to PP showed stimulated phosphorylation of FoxO-3a, as well as of the Bax/Bcl-2 in both NBC concentrations. In the CL/PP treatment, the phosphorylation of Akt1 and the Bax/Bcl-2 were shown to be intensified in SGR-JFH1. This work provides a new insight to the control of hepatitis C, when exposure to CL and PP.